Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of intravenous immunoglobulins on nerve excitability in chronic dysimmune demyelinating neuropathies
2006-006392-21Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2007
- Countries
- 1
01
Overview
Phase 3, single-arm trial of polyvalent human immunoglobulin in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Peripheral nerve excitability. Started Oct 2007; status: active.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2006-006392-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006392-21.